Sees Q2 gross margin 30%.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TWST:
- These 2 ‘Oversold’ Stocks Could Be Ready for a Comeback, Say Analysts
- Twist Bioscience price target lowered to $37 from $43 at Barclays
- Twist Centogene launch target enrichment panels for rare disease diagnosis
- Twist in research pact with with Astellas, eligible for milestone payments
- Twist Bioscience initiated with Outperform, $33 target at Scotiabank